These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8785259)
1. Potential role of rifabutin in prophylaxis for tuberculosis and infections due to multiple opportunistic pathogens. Chaisson RE Clin Infect Dis; 1996 Apr; 22 Suppl 1():S61-6; discussion S66-9. PubMed ID: 8785259 [TBL] [Abstract][Full Text] [Related]
2. Clinical experience with rifabutin in the treatment of mycobacterial infections. De Cian W; Sassella D; Wynne BA Scand J Infect Dis Suppl; 1995; 98():22-6. PubMed ID: 8867175 [TBL] [Abstract][Full Text] [Related]
4. Survival analysis of two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex in AIDS. Moore RD; Chaisson RE AIDS; 1995 Dec; 9(12):1337-42. PubMed ID: 8605053 [TBL] [Abstract][Full Text] [Related]
5. Rifabutin prophylaxis against Mycobacterium avium complex infections in HIV-infected patients: impact on the incidence of campylobacteriosis. Pulik M; Genet P; Leturdu F; Lionnet F; Louvel D; Touahri T AIDS Patient Care STDS; 1999 Aug; 13(8):467-72. PubMed ID: 10800525 [TBL] [Abstract][Full Text] [Related]
6. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS. Cohn DL Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195 [TBL] [Abstract][Full Text] [Related]
7. Pattern of utilization of rifabutin for prophylaxis of Mycobacterium avium complex among patients with advanced human immunodeficiency virus disease in a community setting. Mandigo K; Hogg RS; Phillips P; Barber C; Le T; Bessuille E; Black W; O'Shaughnessy MV; Schechter MT; Montaner JS Tuber Lung Dis; 1996 Jun; 77(3):233-8. PubMed ID: 8758106 [TBL] [Abstract][Full Text] [Related]
8. Azithromycin in the prophylaxis of opportunistic infections in AIDS. McCutchan JA Int J STD AIDS; 1996; 7 Suppl 1():34-7. PubMed ID: 8652726 [TBL] [Abstract][Full Text] [Related]
9. Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators. Holmberg SD; Moorman AC; Von Bargen JC; Palella FJ; Loveless MO; Ward DJ; Navin TR JAMA; 1998 Feb; 279(5):384-6. PubMed ID: 9459473 [TBL] [Abstract][Full Text] [Related]
10. Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Brogden RN; Fitton A Drugs; 1994 Jun; 47(6):983-1009. PubMed ID: 7521834 [TBL] [Abstract][Full Text] [Related]
11. Prophylaxis of Mycobacterium avium complex bacteremia in patients with AIDS. Gordin F; Masur H Clin Infect Dis; 1994 Apr; 18 Suppl 3():S223-6. PubMed ID: 8204774 [TBL] [Abstract][Full Text] [Related]
12. Criteria for use of rifabutin in adult patients with human immunodeficiency virus (HIV)-associated disease. Fish N; Kass CL Am J Health Syst Pharm; 1996 Jul; 53(13):1598-9. PubMed ID: 8809283 [No Abstract] [Full Text] [Related]
13. Prophylaxis for opportunistic infections in patients with HIV infection. Gallant JE; Moore RD; Chaisson RE Ann Intern Med; 1994 Jun; 120(11):932-44. PubMed ID: 8172439 [TBL] [Abstract][Full Text] [Related]
14. Rifabutin-induced hypopyon uveitis in patients with acquired immunodeficiency syndrome infected with Mycobacterium avium complex. Wang HH; Chung YM; Lin YC; Hu HC; Wong WW J Chin Med Assoc; 2007 Mar; 70(3):136-9. PubMed ID: 17389160 [TBL] [Abstract][Full Text] [Related]
15. Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2000 Mar; 49(9):185-9. PubMed ID: 11795500 [TBL] [Abstract][Full Text] [Related]
16. Evaluating the quality of life associated with rifabutin prophylaxis for Mycobacterium avium complex in persons with AIDS: combining Q-TWiST and multiattribute utility techniques. Revicki DA; Simpson KN; Wu AW; LaVallee RL Qual Life Res; 1995 Aug; 4(4):309-18. PubMed ID: 7550179 [TBL] [Abstract][Full Text] [Related]
17. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000. Li J; Munsiff SS; Driver CR; Sackoff J Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767 [TBL] [Abstract][Full Text] [Related]
18. Prophylaxis against Mycobacterium avium-intracellulare complex infections in human immunodeficiency virus-infected patients. Nightingale SD Infection; 1997; 25(1):67-70. PubMed ID: 9039547 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infection. Gaspar MM; Neves S; Portaels F; Pedrosa J; Silva MT; Cruz ME Antimicrob Agents Chemother; 2000 Sep; 44(9):2424-30. PubMed ID: 10952590 [TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]